SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-16-029675
Filing Date
2016-04-20
Accepted
2016-04-19 20:06:21
Documents
4
Period of Report
2016-05-03
Effectiveness Date
2016-04-20

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A insy20160415_def14a.htm DEF 14A 612091
2 insys2.jpg GRAPHIC 146424
3 insys.jpg GRAPHIC 225001
4 insy20160415_def14aimg001.jpg GRAPHIC 1774
  Complete submission text file 0001437749-16-029675.txt   1127300
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35902 | Film No.: 161580182
SIC: 2834 Pharmaceutical Preparations